CTSO Cytosorbents Corporation
3.960USD-0.13%Mkt Cap: 12.48M $P/E: —2d ago
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship pro…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap12.48M USD
Enterprise Value37.74M USD
Revenue (TTM)37.22M USD
Gross Profit26.49M USD
Net Income (TTM)-8.20M USD
Revenue/Share11.86 USD
Last Price3.960 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees129
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)Infinity
PEG—
EV/EBITDA-3.65
EV/Revenue1.01
P/S0.34
P/B-16.95
EPS (TTM)-5.80
EPS (Forward)0.00
52W Range
3.6602% of range20.40
52W High20.40 USD
52W Low3.660 USD
Profitability
Gross Margin71.48%
Oper. Margin-24.58%
EBITDA Margin-27.81%
Profit Margin-22.12%
ROE-138.88%
ROA-18.56%
Growth
Revenue Growth0.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.38M USD
CapEx (TTM)491.00K USD
FCF Margin-9.43%
FCF Yield-28.11%
Net Debt25.01M USD
Net Debt/EBITDA-2.42
Balance Sheet
Debt/Equity4.93
Current Ratio0.66
Quick Ratio0.47
Book Value/Sh-0.24 USD
Cash/Share1.40 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateSep 8, 2026
Analyst Consensus
Rating—
Target (Mean)47.50 USD
Upside (mean)+1099.5%
Target Range15.00 USD – 80.00 USD
15.00+1099.5% to mean80.00
# Analysts2
Ownership
Shares Out.3.15M
Float2.68M
Insiders15.99%
Institutions25.53%
Short Interest
Short Ratio4.8d
Short % Float4.15%
Short % Out.3.83%
Shares Short120.61K
Short (prev mo.)107.90K
Technical
SMA 506.476 (-38.9%)
SMA 20010.41 (-61.9%)
Beta1.34
S&P 52W Chg14.58%
Avg Vol (30d)21.50K
Avg Vol (10d)11.68K
Technical Indicators
RSI (14)25.9
MACD-0.8290
MACD Signal-0.7668
MACD Hist.-0.0622
BB Upper7.390 USD
BB Middle5.167 USD
BB Lower2.944 USD
BB Width86.04%
ATR (14)0.6266 USD
Vol Ratio (20d)1.70x